Chronic Kidney Disease Trial, Recruiting NCT06847139 Sponsor: Chittagong Medical College Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06847139
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have chronic kidney disease and have been receiving haemodialysis (a machine-based kidney treatment) for at least 3 months
  • People whose blood test shows a homocysteine level above 15 µmol/L (homocysteine is a naturally occurring substance in the blood that is measured by a routine test)

Who may not be able to join:

  • People who have an acute (sudden or active) illness at the time of joining the trial
  • People who have been diagnosed with malabsorption (a condition where the body has difficulty absorbing nutrients from food)
  • People who have a major surgery planned
  • People who have had, or are scheduled for, a kidney transplant
  • People who have taken zinc or folic acid supplements within the month before enrolling
  • People currently taking vitamin B12 supplements, corticosteroids (anti-inflammatory medicines), anti-folate or cytotoxic drugs (certain cancer or immune-related medicines), quinolones, tetracyclines, or bisphosphonates (confirm specific medicines with trial site)
  • People with a known allergy or sensitivity to zinc or folic acid

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8801680560222

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chittagong Medical College
Registry
ClinicalTrials.gov
Start date
1 July 2024
Est. completion
30 July 2025

Where this trial is recruiting

Bangladesh

Primary endpoints

change from baseline plasma homocysteine level after intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov